Definition and prevalence
Pain in palliative care is generally considered a complex and subjective experience, shaped by both physiological and psychological factors. It appears to be prevalent among patients with advanced diseases, with estimates suggesting that between 50% and 90% of patients in palliative care experience some level of pain. [1,2] Pain may arise from the disease itself (e.g., tumour growth in cancer), treatment side effects, or related comorbidities, and the severity and type of pain can vary considerably between individuals. [2] For instance, cancer pain is often categorised as somatic, visceral, or neuropathic, depending on tumour location and invasion. [3]
In non-malignant conditions, pain also appears prevalent, though it tends to be under-recognised. Chronic diseases such as chronic obstructive pulmonary disease (COPD), heart failure, and end-stage renal disease may contribute to pain through mechanisms like organ failure, inflammation, or side effects from treatment. [4,5] This pain can be particularly challenging to assess and manage, especially in elderly populations or those with communication difficulties, such as people living with dementia. [5,6]
Pain in palliative care is often further classified into acute, chronic, and malignant categories. Acute pain arises suddenly, typically due to injury or treatment, and may require short-term interventions. [7] Chronic pain, by contrast, persists over longer periods and is often managed differently from acute pain, with a focus on long-term pharmacological strategies, including the use of adjuvant therapies alongside opioids. [3] Malignant pain, often linked to cancer or progressive diseases, presents additional complexities in management, as it can include components of both acute and chronic pain. [3,7]
Types of pain in palliative care
Somatic pain: Typically originating from damage to tissues such as skin, muscles, bones, or joints, somatic pain is often well-localised and described as sharp, aching, or throbbing. It is commonly associated with conditions like bone metastases and musculoskeletal disorders. [8]
Visceral pain: This pain arises from internal organs like the intestines, liver, or heart. It tends to be diffuse and poorly localised, often described as deep, cramping, or pressure-like. Visceral pain may occur in cancer affecting the abdomen or chest, as well as in non-malignant conditions like COPD and heart failure. [4]
Neuropathic pain: Neuropathic pain results from damage or dysfunction of the nervous system, potentially caused by tumour compression or side effects from treatments like chemotherapy. It is often described as burning, shooting, or tingling, and can be more challenging to manage effectively. [2,9]
Assessment
Pain assessment in palliative care requires a multidimensional approach that captures not only pain intensity, but also its impact on a patient's physical, emotional, and psychological well-being. Standardised tools such as the Numerical Rating Scale (NRS) and the Visual Analogue Scale (VAS) are widely used in clinical practice to measure pain intensity across a range of conditions, including cancer and non-cancer diagnoses. [1,10] These tools offer simplicity and ease of use, but they may not fully capture the complexity of the pain experience, particularly when psychological or emotional components are involved. [1,4]
In populations where communication is limited, such as people living with dementia, specific tools like the Pain Assessment in Advanced Dementia (PAINAD) scale are utilised. This tool assesses pain based on observable behavioural cues, such as facial expressions, body movements, and vocalisations, offering a non-verbal means of evaluating pain. [5,11] Despite its usefulness, the PAINAD scale may not always detect more subtle or less overt expressions of pain, particularly in advanced dementia, where symptoms can be misinterpreted as being unrelated to pain. [5] This highlights the importance of frequent reassessment in vulnerable populations.
More comprehensive assessment tools, such as the Brief Pain Inventory (BPI) and the Edmonton Symptom Assessment System (ESAS), are widely used in palliative care to not only measure pain intensity but also assess its impact on the patient’s overall quality of life. [1,4] These tools are valuable because they incorporate the effects of pain on mood, activity, and sleep, providing a holistic view of the patient’s experience. [10] By capturing these broader impacts, healthcare providers can adjust treatment plans to address not only pain but also associated symptoms like anxiety,
fatigue, and depression. [4]
For non-verbal populations or those with cognitive impairments, proxy assessments from caregivers are also important. Caregivers often serve as the primary observers of behavioural changes and are key in providing input on pain-related behaviours when patients cannot effectively communicate their discomfort. [5,6] Consideration should be given to whether the pain requires further investigation, as this can influence treatment decisions. Integrating patient-reported outcomes and pain diaries into regular assessments can also help to track pain patterns over time, especially in home care settings, where formal medical assessments may be less frequent. [4,6]
Non-pharmacological treatment
Non-pharmacological interventions are increasingly recognised as valuable components of pain management in palliative care. While they may not replace pharmacological treatments entirely, evidence suggests they can play a significant complementary role, particularly in enhancing quality of life by addressing the physical, emotional, and psychological aspects of pain. [2,6] Such interventions may be especially useful for patients who are unable to tolerate or prefer to minimise pharmacological treatments.
Light physical activity, where appropriate, has been associated with improvements in pain management and overall well-being. Although physical interventions may not be suitable for all palliative care patients, studies suggest that even modest activity—such as walking, passive stretching, or gentle resistance training—could potentially alleviate musculoskeletal pain by preventing deconditioning. [6,12] The effectiveness of physical interventions may, however, vary depending on individual capacity and the nature of the underlying condition. [8]
Psychological interventions, particularly Cognitive Behavioural Therapy (CBT) and mindfulness-based approaches, are thought to offer benefits by addressing the cognitive and emotional components of pain. CBT has been shown to help patients reframe their thoughts about pain, reducing the emotional distress that often exacerbates pain perception. [10,13] Mindfulness techniques, such as meditation and breathing exercises, are also believed to help by fostering relaxation and reducing anxiety, both of which can contribute to heightened pain experiences. [10] However, individual responses to these therapies may vary, and further research is needed to fully establish their efficacy in palliative care populations. [13]
Complementary treatments, including acupuncture, massage, and music therapy, have shown potential for improving pain management in palliative care. Electroacupuncture has been suggested as a potentially effective treatment for cancer-related pain, with studies indicating that it may reduce pain intensity and decrease the need for opioid medications. [14] Similarly, massage therapy has been reported to improve physical comfort by relieving muscle tension and promoting relaxation, though its effects may be temporary. [6,15] Music therapy is thought to alleviate pain by providing distraction and reducing anxiety, contributing to an improved pain experience. [10,13] While these therapies are generally considered low risk, their effectiveness can be highly individualised and may depend on the patient’s preferences and condition.
Radiation therapy, particularly for bone metastases, is also an important non-pharmacological intervention that can provide significant relief for pain caused by tumour growth. Radiation can help shrink tumours, reduce pressure on surrounding tissues, and improve overall comfort, making it an integral component in the management of cancer pain. [16]
Non-pharmacological approaches such as energy conservation strategies and relaxation techniques are also widely used in palliative care. Task pacing, regular rest periods, and planned activity breaks may help patients manage their energy levels more effectively, particularly when fatigue-related pain is an issue. [4,11] Additionally, relaxation techniques like deep breathing exercises, guided imagery, and progressive muscle relaxation may offer temporary relief from pain by reducing tension and anxiety. [13] These strategies can often be tailored to the individual’s needs and are relatively easy to implement across different care settings.
Although non-pharmacological treatments are unlikely to fully replace traditional pain medications, they appear to offer valuable adjunctive benefits in comprehensive pain management strategies. Their low-risk nature and adaptability make them suitable for a wide range of patients in various care environments, though ongoing assessment of their effectiveness and suitability is required to ensure optimal outcomes. [8,12]
Pharmacological treatment
Pharmacological management remains a primary approach to pain control in palliative care, particularly for moderate to severe pain. Opioids are frequently employed, especially for cancer-related pain, though there is increasing interest in opioid-sparing strategies to mitigate side effects and address concerns about tolerance and dependency. [1,17] These strategies involve using adjuvant medications or non-pharmacological treatments to reduce opioid dosages while maintaining effective pain relief. Medication choices are typically tailored to the individual's pain type, severity, and overall health, and are reassessed as the patient's condition evolves.
Opioids: Strong opioids, including morphine, oxycodone, and hydromorphone, are commonly used for cancer-related pain and other severe pain syndromes. [18,19] These medications are effective in managing somatic and visceral pain, and the World Health Organization’s (WHO) three-step analgesic ladder continues to recommend their use in severe pain scenarios. However, opioids are associated with significant side effects, such as constipation,
nausea, sedation, and the risk of opioid-induced hyperalgesia. [2,19] Moreover, their efficacy in treating neuropathic pain remains contentious, as this type of pain often responds less well to opioid therapy. [1] Consequently, opioid-sparing strategies are increasingly adopted to reduce reliance on opioids by incorporating adjuvant analgesics. [2,17]
Adjuvant Analgesics: For pain that does not respond fully to opioids—especially neuropathic pain—adjuvant medications, including gabapentinoids (gabapentin, pregabalin) and antidepressants (amitriptyline, duloxetine), are frequently used. [1,2] These drugs act on nerve-related pain pathways and are often prescribed alongside opioids to improve overall pain control. While these agents can be effective, they also require careful dosing and monitoring due to potential side effects, such as dizziness, sleepiness, and dry mouth. [6,18]
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs like ibuprofen and celecoxib are commonly used for mild to moderate somatic pain, especially where inflammation is a contributing factor. [17] They are often combined with opioids to enhance pain relief and reduce the required opioid dose. However, long-term NSAID use must be approached cautiously, particularly in patients with gastrointestinal or renal issues, as these drugs can increase the risk of ulcers, gastrointestinal bleeding, and kidney damage. [6,17] In some frail or elderly patients, the risks associated with NSAIDs may outweigh their benefits, necessitating alternative approaches. [9]
Corticosteroids: Corticosteroids such as dexamethasone and prednisolone are commonly prescribed for pain linked to inflammation, including pain due to tumour-related swelling or nerve compression. [17] These medications can provide relatively quick pain relief in such cases, though their long-term use is limited by side effects, including immunosuppression, muscle weakness, and hyperglycaemia. [2] Short courses of corticosteroids are often employed to manage acute pain flares, particularly in terminal phases, with careful monitoring to balance their benefits against potential harm. [1]
Cannabinoids: There is growing interest in the use of cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) for managing chronic and neuropathic pain in palliative care settings. [20,21] Although early evidence suggests cannabinoids may be beneficial for some patients, particularly for neuropathic pain, their efficacy remains uncertain, and side effects such as dizziness, cognitive impairment, and sedation must be considered. [20] Legal and regulatory issues also complicate cannabinoid use in many jurisdictions, and further research is needed to clarify their role in palliative care. [21]
Pharmacological treatments, though essential in palliative care, require a nuanced approach. Balancing the efficacy of medications against their potential side effects is key, particularly in frail or older populations. Multimodal pain management strategies, which incorporate both pharmacological and non-pharmacological interventions, are often recommended to provide comprehensive and holistic care.